Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m2 Prior to Bariatric Surgery

Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m2 Prior to Bariatric Surgery

FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications, have demonstrated weight loss when used for the...

Full description

Bibliographic Details
Main Authors: Cetin Sari, Richard L. Seip, Devika Umashanker
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Endocrinology
Subjects:
generic weight loss medications
preoperative weight loss
anti-obesity pharmacotherapy
pre-surgery
super obesity
medical weight loss
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.588016/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.588016/full

Similar Items